PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
news

CPhI Worldwide Announces New November 2021 Dates

At CPhI Worldwide, we understand the importance of meeting face-to-face with your peers and potential business partners.  In 2021 we will bring the global pharma comm...
Continue Reading →
Regional News

Biden aims to release all available COVID-19 shots in departure from Trump strategy

President Donald Trump's Operation Warp Speed promised 20 million COVID-19 vaccines administered to Americans by the end of 2020. Halfway into January, the roll...
Continue Reading →
Regional News

Herceptin-Perjeta combo, innovation are Roche’s defense against biosimilars, CFO says

In 2020, Roche faced up to its Rubicon: the advent of biosimilars to its trio of top-selling cancer drugs. The copycats eroded $5 billion of sales, but the company s...
Continue Reading →
Regional News

Merck KGaA snaps up mRNA manufacturer AmpTec as pandemic vaccines unlock platform’s future

Pfizer, BioNTech and Moderna's COVID-19 vaccines didn't just prove mRNA could work last year. They absolutely crushed the competition, finishing out 2020 with record...
Continue Reading →
Regional News

Translate Bio targets Q2 data drop on nebulized mRNA therapy

Translate Bio is aiming to deliver data on the first clinical-stage nebulized mRNA therapy early in the second quarter. The biotech set the target after the phase 1/...
Continue Reading →
Regional News

Illumina inks multiple cancer diagnostic partnerships to complement upcoming Grail acquisition

Following its $8 billion pitch last year to acquire Grail and its upcoming multi-tumor blood test, Illumina is planning a deeper dive into cancer genomics with a sle...
Continue Reading →
Regional News

Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services

Formerly Parexel Informatics, Calyx is a market-leading Medical Imaging, eClinical, and Regulatory solutions provider Nottingham, UK – Jan. 11, 2021 — Calyx, ...
Continue Reading →
Regional News

AbbVie’s post-Humira life looks brighter with Skyrizi psoriatic arthritis win

AbbVie’s betting a large part of its post-Humira growth on two new immunology drugs. Now, one of those rising stars, Skyrizi, has delivered a clinical trial win that...
Continue Reading →
Regional News

Regeneron’s CEO and CSO could nab a whopping $1.4B in bonuses—if the pipeline pumps up investors

Regeneron’s share price has dropped by nearly a third in the last six months as excitement over the company’s recently cleared COVID-19 antibody treatment has l...
Continue Reading →
Regional News

Missouri’s Nostrum Labs pulls more metformin over carcinogen concerns

After the FDA noticed a possible carcinogen in popular diabetes med metformin last year, a parade of recalls ensued. Now, less than a week into 2021, one of the drug...
Continue Reading →
Quotient